GR74703B - - Google Patents

Info

Publication number
GR74703B
GR74703B GR66407A GR810166407A GR74703B GR 74703 B GR74703 B GR 74703B GR 66407 A GR66407 A GR 66407A GR 810166407 A GR810166407 A GR 810166407A GR 74703 B GR74703 B GR 74703B
Authority
GR
Greece
Prior art keywords
imidazolin
oxo
esters
salts
image
Prior art date
Application number
GR66407A
Other languages
English (en)
Inventor
Hans-Heiner Dr Lautenschlaeger
Hans Dr Betzing
Briggitte Stoll
Manfred Dr Probst
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of GR74703B publication Critical patent/GR74703B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
GR66407A 1980-11-11 1981-11-03 GR74703B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042466 DE3042466A1 (de) 1980-11-11 1980-11-11 N-substituierte (omega) -(2-oxo-4-imidazolin-l-yl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Publications (1)

Publication Number Publication Date
GR74703B true GR74703B (el) 1984-07-05

Family

ID=6116469

Family Applications (1)

Application Number Title Priority Date Filing Date
GR66407A GR74703B (el) 1980-11-11 1981-11-03

Country Status (9)

Country Link
US (1) US4349684A (el)
EP (1) EP0051829B1 (el)
JP (1) JPS57108073A (el)
AT (1) ATE10626T1 (el)
DE (1) DE3042466A1 (el)
DK (1) DK495781A (el)
GR (1) GR74703B (el)
IE (1) IE52079B1 (el)
ZA (1) ZA817696B (el)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228271A1 (de) * 1982-07-29 1984-02-02 A. Nattermann & Cie GmbH, 5000 Köln Triphenylimidazolyloxyalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
DE3323870A1 (de) * 1983-07-02 1985-01-03 A. Nattermann & Cie GmbH, 5000 Köln Neue imidazol-2-ylthioalkansaeuren und ihre derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
US4598149A (en) * 1984-03-02 1986-07-01 Merck & Co., Inc. 3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
NO890522L (no) * 1988-02-25 1989-08-28 Bayer Ag Substituerte imidazolinoner og imidazolinthioner.
CA2014537A1 (en) * 1989-04-26 1990-10-26 Yoshio Hayashi 4-imidazoline derivatives
GB9019839D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
GB9019840D0 (en) * 1990-09-11 1990-10-24 Smith Kline French Lab Compounds
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
WO1995029163A1 (fr) * 1994-04-27 1995-11-02 Nippon Soda Co., Ltd. Derive d'imidazole et procede de production de ce derive
US6017926A (en) * 1997-12-17 2000-01-25 Merck & Co., Inc. Integrin receptor antagonists
KR20030048081A (ko) * 1997-12-17 2003-06-18 머크 앤드 캄파니 인코포레이티드 인테그린 수용체 길항제를 포함하는 약제학적 조성물
AU7743400A (en) * 1999-10-04 2001-05-10 Merck & Co., Inc. Integrin receptor antagonists
SE0100569D0 (sv) * 2001-02-20 2001-02-20 Astrazeneca Ab New compounds
EP1951679B1 (en) * 2005-08-18 2015-02-18 Synta Pharmaceuticals Corp. Imidazole compounds that modulate hsp90 activity
DE102006024024A1 (de) 2006-05-23 2007-11-29 Bayer Healthcare Aktiengesellschaft Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung
DE102008060967A1 (de) 2008-12-06 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Substituierte Phenylsulfonyltriazolone und ihre Verwendung
DE102010001064A1 (de) 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
CA2791100C (en) 2010-02-27 2018-01-30 Bayer Intellectual Property Gmbh Bisaryl-bonded aryltriazolones and use thereof
DE102010040187A1 (de) 2010-09-02 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung
DE102010040924A1 (de) 2010-09-16 2012-03-22 Bayer Schering Pharma Aktiengesellschaft Substituierte Phenylacet- und Phenylpropanamide und ihre Verwendung
AU2015342017B2 (en) 2014-11-03 2020-02-06 Bayer Pharma Aktiengesellschaft Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
US9988367B2 (en) 2016-05-03 2018-06-05 Bayer Pharma Aktiengesellschaft Amide-substituted pyridinyltriazole derivatives and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2194369B1 (el) * 1972-08-04 1980-04-25 Roussel Uclaf
DE2713431A1 (de) * 1977-03-26 1978-09-28 Bayer Ag Verfahren zur herstellung von diacylierten 4-imidazolinonen-2 und deren verwendung fuer cycloadditionen
DE2934746A1 (de) 1979-08-28 1981-03-19 A. Nattermann & Cie GmbH, 5000 Köln Oxoimidazolinalkansaeuren, deren salze und ester sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2950478A1 (de) 1979-12-14 1981-06-19 A. Nattermann & Cie GmbH, 5000 Köln 4,5-diaryl-4-imidazolin-2-on-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate

Also Published As

Publication number Publication date
EP0051829A1 (en) 1982-05-19
ZA817696B (en) 1982-10-27
JPS57108073A (en) 1982-07-05
EP0051829B1 (en) 1984-12-05
ATE10626T1 (de) 1984-12-15
IE52079B1 (en) 1987-06-10
DE3042466A1 (de) 1982-06-16
IE812565L (en) 1982-05-11
DK495781A (da) 1982-05-12
US4349684A (en) 1982-09-14

Similar Documents

Publication Publication Date Title
IE812565L (en) N-substituted omega-(2-oxo-4-imidazolin-1-yl) alkonoic acids
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
JPS5665892A (en) 6 betaahydroxyalkylpenicillaic acid derivative as betaalactamase inhibitor
LU88670I2 (fr) Fluvastatine eventuellement sous forme de sel par exemple sel de sodium
GR78945B (el)
DE3277970D1 (en) (4-oxo-4h-(1)-benzopyran-8-yl)-alkanoic acids, salts and derivatives, preparation and medicines containing them
DE3372287D1 (en) Process for the preparation of tetrahydropyridines
GR74704B (el)
ZA804365B (en) Mixtures of optical brighteners
GB2053230B (en) Tripeptides of the general formula
GR82125B (el)
SE8401280L (sv) Mellanprodukter och forfaraden for framstellning derav
FI812395L (fi) Alfa-substituerad ureidbensylpenicillinsyra och foerfarande foer framstaellning daerav
IN170286B (el)
ATE73812T1 (de) Thionophosphonsaeureester.
DE3065387D1 (en) Purification of l-aspartyl-l-phenylalanine alkyl esters
IT1138461B (it) Stabilizzazione di dispersioni di sodio
NZ194229A (en) Cyclophosphathiazenes and pharmaceutical compositions
IT1143239B (it) Diestere cicloalifatico e composizione utile per il trattamento di tessili contenete il detto estere
JPS56104857A (en) Nnalkyllcarbamic acid indanee44yl ester* its manufacture and its use as bactericide
GB2118942B (en) 7b-acylamido-3-cephem-4-carboxylic acid compounds of the formula
AT388736B (de) Neue stabile, kristalline formen des ceftazidime-t-butylesters und verfahren zu ihrer herstellung
ZA851157B (en) The use of cephem compounds as immunomodulators
GB2018770A (en) Hexahydro-1-mercaptoacyl-1H- azepine-2-carboxylic acids and esters
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren